Adelseril, which contains the active ingredient sibutramine, was once prescribed for weight management but has been withdrawn from many markets due to safety concerns. Studies indicated that sibutramine may increase the risk of cardiovascular events such as heart attacks and strokes. As a result, its use is generally considered unsafe, and patients are advised to consult healthcare providers for alternative weight loss options. Always prioritize current medical guidelines and consult a healthcare professional before using any medication.
Copyright © 2026 eLLeNow.com All Rights Reserved.